🇺🇸 FDA

Drug profile · INN

indium in-111 pentetate disodium

MPI INDIUM DTPA IN 111

FDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

indium in-111 pentetate disodium (MPI INDIUM DTPA IN 111) is an FDA-listed pharmaceutical active ingredient. Route of administration: intrathecal. Current US regulatory status: approved.

Key facts

INN indium in-111 pentetate disodium
Brand MPI INDIUM DTPA IN 111
Route INTRATHECAL
Formulation INJECTABLE

Frequently asked questions

What is indium in-111 pentetate disodium?

indium in-111 pentetate disodium (MPI INDIUM DTPA IN 111) is an FDA-listed pharmaceutical active ingredient. Route of administration: intrathecal. Current US regulatory status: approved.

What is the brand name for indium in-111 pentetate disodium?

MPI INDIUM DTPA IN 111 is a marketed brand name for indium in-111 pentetate disodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of indium in-111 pentetate disodium?

indium in-111 pentetate disodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.